Nuvectis Pharma
Fort Lee
About Nuvectis Pharma
Nuvectis Pharma is a bio-pharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer. Nuvectis is led by a management team comprised of industry veterans with broad and extensive drug development experience, and a proven track record of clinical and regulatory success. By leveraging our core competencies of target selection, drug profiling, and clinical and regulatory execution we are building our pipeline of product candidates for development in various oncology indications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $46.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2025)
- Ticker: nasdaq:NVCT
- Website: nuvectis.com
- Phone: (201) 614-3151
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/nuvectis-pharma-58547 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.